News

Recent success for often-maligned CTI and its CEO stir global interest

June 7, 2012 /

MATR Sponsor (view all)

Bear Paw Development Corporation is a private non-profit organization created for the purpose of administering programs to help improve regional economic conditions in Hill, Blaine, Liberty, Chouteau and Phillips Counties and the Fort Belknap and Rocky Boy's Indian Reservations.

Cell Therapeutics Inc., the Seattle biotech firm that has alternately raised and dashed investor hopes over the past 20 years, has scored a triple play in recent weeks, gaining European approval for a new drug, buying a phase-three cancer drug at deep discount and finding a major new investor.

The spate of recent news, while drawing little attention from Seattle area media, has left influential national bloggers and websites musing over why CTI’s developments haven’t attracted more investor interest and movement in its stock price. The stock has stayed under $1 for some weeks and is down 40 percent from a year ago.

Mike Flynn

Full Story: http://campaign.r20.constantcontact.com/render?llr=4mpcnkcab&v=001EXWmPNxFGZtYEyywZ030q-LIthPnZUmiwknT95KYvuHCiSGoGWwridSGumYO1aHxw7_ZrS5LZGl_ERpoEgR6sZXTSjNl12ST5kbH7UB3fwpb4SYw2dfA7u9AT9N91V0h